154
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Comparison of analgesia, adverse effects, and quality of life in cancer patients during treatment of procedural pain with intravenous morphine, fentanyl nasal spray, and fentanyl buccal tablets

, &
Pages 1587-1600 | Published online: 18 Feb 2019

References

  • HaugenDFHjermstandMJHagenNCaraceniAKassaSEuropean Palliative Care Research Collaborative (EPCRC)Assessment and classification of cancer breakthrough pain: a systematic literature reviewPain201014947648220236762
  • ManchikontiLSinghVCarawajDLBreakthrough pain in chronic non– cancer pain: fact, fiction or abusePain Physican201114103117
  • PortenoyRKHagenNABreakthrough pain: definition, prevalence and characteristicsPain19904132732811697056
  • DaviesANDickmanAReidCStevensAMZeppetellaGScience Committee of the Association for Palliative Medicine of Great Britain and IrelandThe management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and IrelandEur J Pain200913433133818707904
  • LøhreETKlepstadPBennettMIFrom “breakthrough” to “episodic” cancer pain? A European Association for Palliative Care Research Network Expert Delphi Survey toward a common terminology and classification of transient cancer pain exacerbationsJ Pain Symptom Manage20165161013101926921493
  • BobbBTCoynePJWhen cancer pain breaks through, what can you do?Oncology20102410 Available from: http://www.cancer-network.com/oncology-nursing/when-cancer-pain-breaks-through-what-can-you-doAccessed October 1, 2018
  • BennettDBurtonAWFishmanSConsensus panel recommendations for the assessment and management of breakthrough pain. Part I assessmentP&T200530296301
  • VellucciRMediatiRDGasperoniSMammucariMMarinangeliMRomualdiPAssessment and treatment of breakthrough cancer pain: from theory to clinical practiceJ Pain Res2017102147215529066928
  • SchmidtRSchmelzMRingkampMHandwerkerHOTorebjörkHEInnervation territories of mechanically activated C nociceptor units in human skinJ Neurophysiol1997785264126489356413
  • LeppertWMajkowiczMPolish brief pain inventory for pain assessment and monitoring of pain treatment in patients with cancerJ Palliat Med201013666366820557234
  • LeppertWMajkowiczMValidation of the polish version of the European organization for research and treatment of cancer quality of life questionnaire – core 15 – palliative care in patients with advanced cancerPalliat Med201327547047722988041
  • FolsteinMFolsteinSEMcHughPR“Mini-Mental State” a practical method for grading the cognitive state of patients for the clinicianJ Psychiatr Res1975121891981202204
  • FayersPMAaronsonNBjordalKGroenvoldMCurranDBottomleyAThe EORTC QLQ-C30 Scoring Manual3rd edBrusselsEuropean Organization for Research and Treatment of Cancer2001
  • GroenvoldMPetersenMAOn Behalf of the EORTC Quality of Life GroupAddendum to the EORTC QLQ-C30 scoring manual: scoring of the EORTC QLQ-C15-PALBrussels, BelgiumEORTC Quality of Life Unit2006
  • FallonMGiustiRAielliFOn Behalf of the ESMO Guidelines CommitteeManagement of cancer pain in adult patients: ESMO clinical practice guidelinesAnn Oncol201829suppl. 4iv149iv174
  • SevarinoFBGinsbergBLichtorJLOral Transmucosal Fentanyl Citrate (OTFC) compared with IV morphine for acute pain in patients following abdominal surgeryAnesth Analg199784S330
  • ZeppetellaGOpioids for cancer breakthrough pain: a pilot study reporting patient assessment of time to meaningful pain reliefJ Pain Symptom Manage200835556356718258412
  • ColuzziPHSchwartzbergLConroyJDBreakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR)Pain20019112313011240084
  • HanksGWNugentMHiggsCMBBuschMAOTFC Multicentre Study GroupOral transmucosal fentanyl citrate in the management of breakthrough pain in cancer: an open, multicentre, dose-titration and long-term use studyPalliat Med200418869870415623166
  • OsborneRJoelSTrewDSlevinMMorphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronideClin Pharmacol Ther199047112192295214
  • KongsgaardUEEegMGreisenHThe use of Instanyl in the treatment of breakthrough pain in cancer patients: a 3-month observational, prospective, cohort studySupport Care Cancer20142261655166224510192
  • PergolizziJBögerRHBuddKOpioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone)Pain Pract20088428731318503626
  • CleelandCSThe impact of pain on the patient with cancerCancer19845411 Suppl263526416498754